FHL2 expression and variants in hypertrophic cardiomyopathy
FHL2 expression and variants in hypertrophic cardiomyopathy
About this item
Full title
Author / Creator
Friedrich, Felix W. , Reischmann, Silke , Schwalm, Aileen , Unger, Andreas , Ramanujam, Deepak , Münch, Julia , Müller, Oliver J. , Hengstenberg, Christian , Galve, Enrique , Charron, Philippe , Linke, Wolfgang A. , Engelhardt, Stefan , Patten, Monica , Richard, Pascale , van der Velden, Jolanda , Eschenhagen, Thomas , Isnard, Richard and Carrier, Lucie
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Based on evidence that FHL2 (four and a half LIM domains protein 2) negatively regulates cardiac hypertrophy we tested whether
FHL2
altered expression or variants could be associated with hypertrophic cardiomyopathy (HCM). HCM is a myocardial disease characterized by left ventricular hypertrophy, diastolic dysfunction and increased interstiti...
Alternative Titles
Full title
FHL2 expression and variants in hypertrophic cardiomyopathy
Authors, Artists and Contributors
Author / Creator
Reischmann, Silke
Schwalm, Aileen
Unger, Andreas
Ramanujam, Deepak
Münch, Julia
Müller, Oliver J.
Hengstenberg, Christian
Galve, Enrique
Charron, Philippe
Linke, Wolfgang A.
Engelhardt, Stefan
Patten, Monica
Richard, Pascale
van der Velden, Jolanda
Eschenhagen, Thomas
Isnard, Richard
Carrier, Lucie
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4215105
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4215105
Other Identifiers
ISSN
0300-8428
E-ISSN
1435-1803
DOI
10.1007/s00395-014-0451-8
